Back
von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse models
Journal article

von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse models

  • Brill, Alexander Department of Pathology, Harvard Medical School, Boston, MA;
  • Fuchs, Tobias A. Department of Pathology, Harvard Medical School, Boston, MA;
  • Chauhan, Anil K. Department of Pathology, Harvard Medical School, Boston, MA;
  • Yang, Janie J. Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, MA;
  • De Meyer, Simon F. Department of Pathology, Harvard Medical School, Boston, MA;
  • Köllnberger, Maria Deutsches Herzzentrum, Technische Universität München, Munich, Germany;
  • Wakefield, Thomas W. Cardiovascular Center, University of Michigan, Ann Arbor, MI; and
  • Lämmle, Bernhard Department of Haematology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
  • Massberg, Steffen Deutsches Herzzentrum, Technische Universität München, Munich, Germany;
  • Wagner, Denisa D. Department of Pathology, Harvard Medical School, Boston, MA;
Show more…
Published in:
  • Blood. - American Society of Hematology. - 2011, vol. 117, no. 4, p. 1400-1407
English Abstract
Deep vein thrombosis (DVT) and its complication, pulmonary embolism, are frequent causes of disability and mortality. Although blood flow disturbance is considered an important triggering factor, the mechanism of DVT initiation remains elusive. Here we show that 48-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi structurally similar to human deep vein thrombi. von Willebrand factor (VWF)–deficient mice were protected from thrombosis induced by complete (stasis) or partial (stenosis) flow restriction in the IVC. Mice with half normal VWF levels were also protected in the stenosis model. Besides promoting platelet adhesion, VWF carries Factor VIII. Repeated infusions of recombinant Factor VIII did not rescue thrombosis in VWF−/− mice, indicating that impaired coagulation was not the primary reason for the absence of DVT in VWF−/− mice. Infusion of GPG-290, a mutant glycoprotein Ibα-immunoglobulin chimera that specifically inhibits interaction of the VWF A1 domain with platelets, prevented thrombosis in wild-type mice. Intravital microscopy showed that platelet and leukocyte recruitment in the early stages of DVT was dramatically higher in wild-type than in VWF−/− IVC. Our results demonstrate a pathogenetic role for VWF-platelet interaction in flow disturbance-induced venous thrombosis.
Language
  • English
Open access status
green
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/217507
Statistics
Document views: 75 File downloads: